DYN — DYNE THERAPEUTICS INC

Ownership history in VR Adviser, LLC  ·  11 quarters on record

This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in DYNE THERAPEUTICS INC (DYN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.89% (2024 Q2)
Avg. % of fund
2.77%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 2,173,913 — 0% 2.10% $42.5M $19.56
2025 Q3 UNCHANGED 2,173,913 — 0% 1.55% $27.5M $12.65
2025 Q2 UNCHANGED 2,173,913 — 0% 1.55% $20.7M $9.52
2025 Q1 UNCHANGED 2,173,913 — 0% 1.93% $22.7M $10.46
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DYN price (monthly, adj. close)

Other funds also holding DYN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 20.64% FCPM III SERVICES B.V. 14.01% Saturn V Capital Management LP 3Y 6.42% Palo Alto Investors LP 3Y 7Y 4.01% Vivo Capital, LLC 3Y 7Y 3.31% MPM BioImpact LLC 3Y 3.15% TCG Crossover Management, LLC 3Y 2.99% STEMPOINT CAPITAL LP 2.8% Siren, L.L.C. 2.04% Sofinnova Investments, Inc. 3Y 7Y 1.9%
← Back to VR Adviser, LLC Holdings